basaglar.lilly.com Open in urlscan Pro
54.162.128.250  Public Scan

Form analysis
0 forms found in the DOM

Text Content

PRIVACY PREFERENCES

Lilly collects information about your online interactions, such as user ID,
browsing history, geolocation and IP address, through tracking technologies,
such as third-party cookies..... You may accept, decline or withdraw your
consent to most cookies and tracking technologies on this site, other than those
that are necessary for the site operations and functionality, by clicking one of
the options below. We use this information to personalize content, save your
preferences, and track website performance. We share information with our
analytics, marketing, and advertising partners for purposes of targeted
advertising and analyzing website metrics. Please visit our Cookie Notice,
Privacy Statement, and Consumer Health Privacy Notice for more information.
Certain laws require consent to collect and share information. You can withdraw
your consent at any time through the Cookie Settings or Your Privacy Choices in
our website footer. View More

Users located in Washington or Nevada must use this link to Decline All



Accept All Decline All Manage Cookie Settings


GPC DETECTED

We have detected a Global Privacy Control (GPC) signal, please confirm if you
wish to accept all cookies including or excluding those flagged as GPC.

GPC Detected Accept All Excluding GPC Back




×




MANAGE YOUR COOKIE SETTINGS

For more information about Lilly's cookies, tracking technologies and
third-party cookies, see our  Cookie Notice.

You appear to be in a location where some cookies cannot be enabled.



Accept All
On
User Consent Legitimate Interests


STRICTLY NECESSARY COOKIES

Always On



These cookies are necessary for the website to function properly and cannot be
switched off in our systems. Strictly necessary cookies cannot be disabled. For
example, these cookies may enable us to optimize page and content loading,
distribute and manage site traffic, detect bugs and errors and block malicious
traffic and suspicious activity. In addition, these cookies may enable third
party-supported features that you use, such as video players and chat tools, and
other key site functionality, such as webforms.



STRICTLY NECESSARY COOKIE

Strictly Necessary Cookie


FUNCTIONAL COOKIES

On



These cookies and similar technologies remember choices you make such as
language or search parameters. We use these cookies to improve your user
experience and to make your use of the websites more tailored. If you do not
allow these cookies, then some or all of these services may not function as
designed.



FUNCTIONAL COOKIES V3

On



These cookies and similar technologies remember choices you make such as
language or search parameters. We use these cookies to improve your user
experience and to make your use of the websites more tailored. If you do not
allow these cookies, then some or all of these services may not function as
designed.




PERFORMANCE COOKIES (ANALYTICS)

On



These cookies allow Lilly to analyze visits and traffic sources so we can
measure and improve the performance of our sites. They help us to know which
pages are the most and least popular, and see how visitors move around the site
to improve the site’s performance.



PERFORMANCE COOKIES (ANALYTICS) V3

On



These cookies allow Lilly to analyze visits and traffic sources so we can
measure and improve the performance of our sites. They help us to know which
pages are the most and least popular, and see how visitors move around the site
to improve the site’s performance.




ADVERTISING AND MARKETING COOKIES

On



These cookies and similar technologies enable our advertising and marketing
partners to provide behavioral advertising and use functionalities like social
media pixels to track your online activity across social platforms and websites,
which can identify you, as described in the Privacy Statement and Consumer
Health Privacy Notice. These methods create a profile of your activity for our
business and commercial purposes and enable Lilly and our advertising partners
to customize offers and information (online or in person) to you based on your
profile, and profiles of persons with similar interests, that may enhance your
interactions with Lilly.



ADVERTISING AND MARKETING COOKIES V3

On



These cookies and similar technologies enable our advertising and marketing
partners to provide behavioral advertising and use functionalities like social
media pixels to track your online activity across social platforms and websites,
which can identify you, as described in the Privacy Statement and Consumer
Health Privacy Notice. These methods create a profile of your activity for our
business and commercial purposes and enable Lilly and our advertising partners
to customize offers and information (online or in person) to you based on your
profile, and profiles of persons with similar interests, that may enhance your
interactions with Lilly.





Save Settings

Open Cookie Settings

Skip to main content

 * Prescribing Information
 * Patient Information
 * Instructions for Use

Menu Menu
Menu closed
Close Close
 * Prescribing Information
 * Patient Information
 * Instructions for Use

 * House For Patients
    * What is BASAGLAR
    * How to Use BASAGLAR
    * Savings & Resources
   
    * LillyDirect: Ask a Doctor   External Link

 * For Healthcare Providers

Chat Contact Us
Close Contact Us
Ask Lilly

We're here to help.

Phone Call:
(800) LillyRx
(800) 545-5979
Chat Click to Chat
Chat Click to Chat
Expand contact lilly
Globe English Reveal available languages
EnglishEspañol

Actor portrayal. Not an actual patient.


BASAGLAR® (INSULIN GLARGINE) INJECTION 100 UNITS/ML IS YOUR BEGINSULIN®

In patients with type 1 diabetes, BASAGLAR must be used with mealtime insulin.

INDICATION

BASAGLAR is a long-acting insulin that is only available with a prescription. It
is used to control high blood sugar in:

 * adults with type 1 or type 2 diabetes
 * children with type 1 diabetes

LIMITATION OF USE

BASAGLAR is not used to treat diabetic ketoacidosis.

It is not known if BASAGLAR is safe and effective in children with type 2
diabetes or in children younger than 6 years with type 1 diabetes. There were no
studies done with BASAGLAR in these groups of children. If your doctor decides
to give your child BASAGLAR, he or she may give you special instructions.

SELECT SAFETY INFORMATION

Warnings

Do not take BASAGLAR if you have:

 * symptoms of low blood sugar (hypoglycemia) or
 * an allergy to BASAGLAR or any of its ingredients.


NEED HELP PAYING FOR YOUR BASAGLAR PRESCRIPTION?

Lilly is committed to helping people with diabetes access affordable medicines.

Download your $35/month Insulin Savings Card

I have commercial insurance
I pay cash


Through the Lilly Insulin Value Program, all Lilly insulins are available for
$35 a month whether you have commercial insurance or no insurance.*

These savings cover all Lilly insulins.

*Terms and conditions apply. At retail pharmacies. Government restrictions
exclude people enrolled in federal government insurance programs from Lilly's
$35 solutions. But federal law provides that Medicare Part D beneficiaries also
pay no more than $35 per month for insulin.

Learn more about the Lilly Insulin Affordability Program

Terms, Conditions and Limitations apply to the Insulin Value Savings Card. Click
on the following sections for details.


EXPAND ACCORDION CASH SAVINGS CARD TERMS AND CONDITIONS

By using the Lilly Insulin Value Cash Savings Card Program (“Card”), you attest
that you meet the eligibility criteria, and you agree to comply with the terms
and conditions described below:

Card Eligibility:

 1. You have been prescribed one of the following Lilly Insulin Value products
    (“Covered Insulin”) consistent with FDA approved product labeling: BASAGLAR®
    KwikPen® (insulin glargine) injection (100 units/mL), BASAGLAR ® Tempo Pen®,
    Humalog® U-100 cartridge (insulin lispro) injection (100 units per mL),
    Humalog® U-100 KwikPen®, Humalog® U-100 vial (10 mL), Humalog® Junior
    KwikPen®, Humalog® U-200 KwikPen®, Humalog® Mix50/50™ KwikPen® (insulin
    lispro protamine and insulin lispro) injectable suspension (100 units per
    mL), Humalog® Mix50/50™ vial (10 mL), Humalog® Mix75/25™ KwikPen®(insulin
    lispro protamine and insulin lispro) injectable suspension (100 units per
    mL), Humalog® Mix75/25™ vial (10 mL), Humalog® Tempo Pen®, Humulin® N
    KwikPen®(insulin isophane human) injectable suspension (100 units per mL) ,
    Humulin® N vial (10 mL), Humulin® 70/30 KwikPen® (insulin isophane human and
    insulin human) injectable suspension (100 units per mL) , Humulin® 70/30
    vial (10 mL), Humulin® R (insulin human) injection (10 mL), Humulin® R U-500
    KwikPen® (insulin human) injection (500 units/mL), Humulin R U-500 vial,
    Insulin Lispro KwikPen® injection (100 units per mL), Insulin Lispro
    injection vial (10mL), Insulin Lispro Junior KwikPen® injection, Insulin
    Lispro Protamine and Insulin Lispro Mix75/25™ KwikPen® Injectable
    Suspension, Lyumjev® KwikPen® (insulin lispro-aabc) injection (100
    units/mL), Lyumjev® U-200 KwikPen®, Lyumjev® U-100 vial (10 mL), Lyumjev®
    Tempo Pen®, and REZVOGLAR™ KwikPen (insulin glargine-aglr) injection (100
    units/mL).
 2. You are not enrolled in any state, federal, or government funded healthcare
    program, including, without limitation, Medicaid, Medicare, Medicare Part D,
    Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state
    prescription drug assistance program.
 3. You are a resident of the United States or a United States Territory (Puerto
    Rico, Guam, U.S. Virgin Islands, Northern Mariana Islands, American Samoa)
 4. You are 18 years of age or older

Card Terms and Conditions
You must have a prescription consistent with FDA-approved product labeling to
pay as little as $35 for a 1-month prescription fill of your Covered Insulin.
Month is defined as 30-days. Card savings are subject to a maximum monthly
savings of wholesale acquisition cost plus usual and customary pharmacy charges
per prescription fill, up to a maximum of 14 prescription fills per calendar
year for each Covered Insulin. Subject to Lilly USA, LLC’s (“Lilly”) right to
terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms
and conditions which may occur at Lilly’s sole discretion, without notice, and
for any reason, Card expires and savings end on 12/31/2024.

Additional Program Terms and Conditions
If you have an insurance plan that is participating in an alternate funding
program (“AFP”) (examples include, but are not limited to, ImpaxRX, Payer
Matrix, SHARx, Script Sourcing, and Paydhealth) that requires you to apply to
the Lilly Insulin Value Cash Savings Card Program or otherwise pursue specialty
drug prescription coverage through an alternate funding vendor as a condition
of, requirement for, or prerequisite to coverage of your Covered Insulin, you
are not eligible for and are prohibited from using the Lilly Insulin Value Cash
Savings Card Program. AFPs include programs where coverage, reimbursement, or
patient out of pocket costs for a product in some way vary based on the
availability of a manufacturer co-pay program. AFPs may modify, delay, deny,
restrict, or withhold insurance benefits or coverage from patients, or exclude
Lilly products from coverage contingent upon a member's use of Lilly Insulin
Value Cash Savings Card Program. You agree to inform Lilly Insulin Value Cash
Savings Card Program if you are or become a member of such an alternative
funding program. You are responsible for any applicable taxes, fees, and any
amount that exceeds the monthly or annual maximum Card savings. Monthly and
annual maximum savings are set at Lilly's sole and absolute discretion and may
be changed with or without notice at any time for any reason. At its sole
discretion and with or without notice, Lilly may reduce, eliminate, or otherwise
modify the Card savings for any reason including but not limited to if your
commercial drug insurance plan imposes additional requirements which limits or
prevents you from receiving coverage for your Covered Insulin, only allows
partial coverage for your Covered Insulin, removes coverage for your Covered
Insulin and requires you to utilize the Card, does not provide a material level
of financial assistance for the cost of your Covered Insulin, or does not apply
Card payments to satisfy your co-payment, deductible, or coinsurance for your
Covered Insulin. Card savings are not valid for: Massachusetts residents if an
AB-rated generic equivalent is available; California residents if an
FDA-approved therapeutic equivalent is available. You must meet the Card
eligibility criteria, terms and conditions every time you use the Card. Card
activation is required. No party may seek reimbursement from your health
insurance, any third party, or any health savings, flexible spending, or other
healthcare reimbursement accounts, for any amount of the savings received
through the Card. Card savings cannot be combined or utilized with any other
program, discount, discount card, cash discount card, coupon, incentive, or
similar offer involving your Covered Insulin. You agree that this Card savings
is intended solely for the benefit of you, the patient, and that the Card
benefits are nontransferable. It is prohibited for any person to sell, purchase,
or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card.
The Card is not insurance. Lilly has the sole right to interpret and apply Card
eligibility criteria, and terms and conditions. Card eligibility, and terms and
conditions may be terminated, rescinded, revoked, or amended by Lilly at any
time without notice and for any reason. Eligibility criteria, and terms and
conditions for the Lilly Insulin Value Cash Savings Card Program may change from
time to time; the most current version can be found at
https://www.insulinaffordability.com. You may be required to obtain a new Card,
including if any Card terms and conditions have been terminated, rescinded,
revoked, or amended by Lilly. Card void where prohibited by law. Subject to
Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria
and/or Card terms and conditions which may occur at Lilly’s sole discretion,
without notice, and for any reason, the Card expires and savings end on
12/31/2024.


EXPAND ACCORDION COMMERCIAL SAVINGS CARD TERMS AND CONDITIONS

By using the Lilly Insulin Value Savings Card Program (“Card”), you attest that
you meet the eligibility criteria, and you agree to comply with the terms and
conditions described below:

Card Eligibility:

 1. You have been prescribed one of the following Lilly Insulin Value products
    (“Covered Insulin”) consistent with FDA approved product labeling: BASAGLAR®
    KwikPen® (insulin glargine) injection (100 units/mL), BASAGLAR ® Tempo Pen®,
    Humalog® U-100 cartridge (insulin lispro) injection (100 units per mL),
    Humalog® U-100 KwikPen®, Humalog® U-100 vial (10 mL), Humalog® Junior
    KwikPen®, Humalog® U-200 KwikPen®, Humalog® Mix50/50™ KwikPen® (insulin
    lispro protamine and insulin lispro) injectable suspension (100 units per
    mL), Humalog® Mix50/50™ vial (10 mL), Humalog® Mix75/25™ KwikPen®(insulin
    lispro protamine and insulin lispro) injectable suspension (100 units per
    mL), Humalog® Mix75/25™ vial (10 mL), Humalog® Tempo Pen®, Humulin® N
    KwikPen®(insulin isophane human) injectable suspension (100 units per mL) ,
    Humulin® N vial (10 mL), Humulin® 70/30 KwikPen® (insulin isophane human and
    insulin human) injectable suspension (100 units per mL) , Humulin® 70/30
    vial (10 mL), Humulin® R (insulin human) injection (10 mL), Humulin® R U-500
    KwikPen® (insulin human) injection (500 units/mL), Humulin R U-500 vial,
    Insulin Lispro KwikPen® injection (100 units per mL), Insulin Lispro
    injection vial (10mL), Insulin Lispro Junior KwikPen® injection, Insulin
    Lispro Protamine and Insulin Lispro Mix75/25™ KwikPen® Injectable
    Suspension, Lyumjev® KwikPen® (insulin lispro-aabc) injection (100
    units/mL), Lyumjev® U-200 KwikPen®, Lyumjev® U-100 vial (10 mL), Lyumjev®
    Tempo Pen®, and REZVOGLAR™ KwikPen (insulin glargine-aglr) injection (100
    units/mL).
 2. You are enrolled in a commercial drug insurance plan
 3. You are not enrolled in any state, federal, or government funded healthcare
    program, including, without limitation, Medicaid, Medicare, Medicare Part D,
    Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state
    prescription drug assistance program.
 4. You are a resident of the United States or a United States Territory (Puerto
    Rico, Guam, U.S. Virgin Islands, Northern Mariana Islands, American Samoa)
 5. You are 18 years of age or older

Card Terms and Conditions

For patients with commercial drug insurance coverage for your Covered Insulin:
You must have commercial drug insurance that covers your Covered Insulin and a
prescription consistent with FDA-approved product labeling to pay as little as
$35 for a 1-month prescription fill of your Covered Insulin. Month is defined as
30-days. Card savings are subject to a maximum monthly savings of up to $3,000
per prescription fill of each Covered Insulin and separate maximum annual
savings of up to $16,000 per calendar year for each Covered Insulin. Card may be
used for a maximum of up to 16 prescription fills per calendar year for each
Covered Insulin. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate,
rescind, revoke, or amend Card eligibility criteria and/or Card terms and
conditions which may occur at Lilly’s sole discretion, without notice, and for
any reason, Card expires and savings end on 12/31/2024.

For patients with commercial drug insurance who do not have coverage for your
Covered Insulin: You must have commercial drug insurance that does not cover
your Covered Insulin and a prescription consistent with FDA-approved product
labeling to pay as little as $35 for a 1-month prescription fill of your Covered
Insulin. Month is defined as 30-days. Card savings are subject to a maximum
monthly savings of wholesale acquisition cost plus usual and customary pharmacy
charges per prescription fill, up to a maximum of 14 prescription fills per
calendar year for each Covered Insulin. Subject to Lilly’s right to terminate,
rescind, revoke, or amend Card eligibility criteria and/or Card terms and
conditions which may occur at Lilly’s sole discretion, without notice, and for
any reason, Card expires and savings end on 12/31/2024.

Additional Program Terms and Conditions
If you have an insurance plan that is participating in an alternate funding
program (“AFP”) (examples include, but are not limited to, ImpaxRX, Payer
Matrix, SHARx, Script Sourcing, and Paydhealth) that requires you to apply to
the Lilly Insulin Value Savings Card Program or otherwise pursue specialty drug
prescription coverage through an alternate funding vendor as a condition of,
requirement for, or prerequisite to coverage of your Covered Insulin, you are
not eligible for and are prohibited from using the Lilly Insulin Value Savings
Card Program. AFPs include programs where coverage, reimbursement, or patient
out of pocket costs for a product in some way vary based on the availability of
a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or
withhold insurance benefits or coverage from patients, or exclude Lilly products
from coverage contingent upon a member’s use of Lilly Insulin Value Savings Card
Program. You agree to inform Lilly Insulin Value Savings Card Program if you are
or become a member of such an alternative funding program. You are responsible
for any applicable taxes, fees, and any amount that exceeds the monthly or
annual maximum Card savings. Monthly and annual maximum savings are set at
Lilly’s sole and absolute discretion and may be changed with or without notice
at any time for any reason. At its sole discretion and with or without notice,
Lilly may reduce, eliminate, or otherwise modify the Card savings for any
reason, including but not limited to if your commercial drug insurance plan
imposes additional requirements which limits or prevents you from receiving
coverage for your Covered Insulin, only allows partial coverage for your Covered
Insulin, removes coverage for your Covered Insulin and requires you to utilize
the Card, does not provide a material level of financial assistance for the cost
of your Covered Insulin, or does not apply Card payments to satisfy your
co-payment, deductible, or coinsurance for your Covered Insulin. Card savings
are not valid for: Massachusetts residents if an AB-rated generic equivalent is
available; California residents if an FDA-approved therapeutic equivalent is
available. You must meet the Card eligibility criteria, terms and conditions
every time you use the Card. Card activation is required. No party may seek
reimbursement from your health insurance, any third party, or any health
savings, flexible spending, or other healthcare reimbursement accounts, for any
amount of the savings received through the Card. By utilizing the Card, you
agree that if you are required to do so under the terms of your insurance
coverage for this prescription or are otherwise required to do so by law, you
will notify your Insurance Carrier of your redemption of the Card. Card savings
cannot be combined or utilized with any other program, discount, discount card,
cash discount card, coupon, incentive, or similar offer involving your Covered
Insulin. You agree that this Card savings is intended solely for the benefit of
you, the patient, and that the Card benefits are nontransferable. It is
prohibited for any person to sell, purchase, or trade; or to offer to sell,
purchase, or trade, or to counterfeit the Card. The Card is not insurance. Lilly
has the sole right to interpret and apply Card eligibility criteria, and terms
and conditions. Card eligibility, and terms and conditions may be terminated,
rescinded, revoked, or amended by Lilly at any time without notice and for any
reason. Eligibility criteria, and terms and conditions for the Lilly Insulin
Value Savings Card Program may change from time to time; the most current
version can be found at https://www.insulinaffordability.com. You may be
required to obtain a new Card, including if any Card terms and conditions have
been terminated, rescinded, revoked, or amended by Lilly. Card void where
prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or
amend Card eligibility criteria and/or Card terms and conditions which may occur
at Lilly’s sole discretion, without notice, and for any reason, the Card expires
and savings end on 12/31/2024.

Anyone who uses Lilly insulin and needs help with diabetes care can call the
Lilly Diabetes Solution Center. A live representative will have a confidential
conversation and present solutions that are based on each person's
circumstances. The helpline is available Monday through Friday.

Call 1-833-808-1234

Solutions vary by product and are subject to change and eligibility.


WHEN IT’S TIME TO START TAKING INSULIN, YOU MAY WONDER WHAT IT’S LIKE TO BEGIN
OR HOW TO FIT IT INTO YOUR LIFE

Your doctor recommended BASAGLAR because it’s a long-acting insulin, which means
it’s a good place to begin for people new to insulin.

Learn more about BASAGLAR

Answers to your questions about insulin

It’s normal to have a lot of questions when starting insulin. Whether you and
your doctor are still discussing insulin or you’ve already been prescribed
BASAGLAR, you’ve come to the right place. See what insulin is and how it may
help people with diabetes.



Wondering about your routine with insulin?

We’ll explain how to use BASAGLAR, ways you can establish a good routine, where
to inject, and more.

SELECT SAFETY INFORMATION
Warnings
Do not reuse needles or share your Basaglar prefilled pen with other people. You
or the other person can get a serious infection. This can happen even if you
change the needle.



Looking for resources designed to help you start insulin?

BASAGLAR goes beyond just insulin by offering support you may need. Check out
our resources designed to help you start basal insulin therapy, support that may
help you save on BASAGLAR, and contacts for additional support.

SELECT SAFETY INFORMATION
Warnings
Do not change the insulin you use or your dose, unless your doctor tells you to.
This could cause low or high blood sugar, which could be serious. Do not inject
your insulin into the exact same spot or where the skin has pit or lumps. Avoid
injecting into thickened, tender, bruised, scaly, hard, or damaged skin.



LillyDirect: Connect to Care

Get speed, convenience, and access to focused care with independent telehealth
or in-person providers through LillyDirect.

Get started

LillyDirect™ is a trademark owned or licensed by Eli Lilly and Company, its
subsidiaries, or affiliates. All rights reserved.



Important Safety Information and Indication or Indications. Select to Expand.
SAFETY SUMMARY INDICATION Important Safety Information and Indication or
Indications. Select to Expand.
Important Safety Information. Select to Expand. SAFETY SUMMARY Important Safety
Information. Select to Expand.


SAFETY SUMMARY


WARNINGS -

Do not take BASAGLAR if you have:


 * symptoms of low blood sugar (hypoglycemia)
 * an allergy to BASAGLAR or any of its ingredients



Do not reuse needles or share your BASAGLAR prefilled pen with other people. You
or the other person can get a serious infection. This can happen even if you
change the needle.

Do not change the insulin you use or your dose, unless your doctor tells you to.
This could cause low or high blood sugar, which could be serious.

BASAGLAR may cause serious side effects. Some of these can lead to death. The
possible serious side effects of BASAGLAR are:

 * Low blood sugar. This can lead to:
    * dizziness or light-headedness
    * headache
    * shakiness
    * irritability
   
    * sweating
    * blurred vision
    * fast heartbeat
    * mood change
   
    * confusion
    * slurred speech
    * anxiety
    * hunger

 * Severe allergic reaction.
   Get emergency help right away if you have:
    * a rash over your whole body
    * swelling of your face, tongue, or throat
    * extreme drowsiness, dizziness, or confusion
   
    * trouble breathing
    * sweating
   
    * a fast heartbeat
    * shortness of breath

 * Low potassium in your blood. This can lead to severe breathing problems,
   irregular heartbeat, and death.
 * Heart failure. Taking diabetes pills called thiazolidinediones
   /thIE-uh-zOH-li-dEEn-dIE-OHns/ (TZDs) with BASAGLAR may cause heart failure
   in some people. This includes people who do not have any heart problems. If
   you have heart failure, it may get worse if you take TZDs with BASAGLAR. Tell
   your doctor if you have any new symptoms of heart failure, or if they get
   worse. These are: shortness of breath, swelling of the ankles or feet, and
   sudden weight gain. Your doctor may need to change or stop treatment with
   TZDs and BASAGLAR.

Common side effects

The most common side effects of BASAGLAR are:

 * low blood sugar
 * minor reactions where you have injected BASAGLAR
 * itching
 * swelling

 * allergic reactions
 * changes in fat tissue where you have injected BASAGLAR
 * rash
 * weight gain

These are not all of the possible side effects. Tell your doctor if you have any
side effects. You can report side effects at 1-800-FDA-1088 or
www.fda.gov/medwatch.

BEFORE USING

Talk with your doctor about low blood sugar and how to manage it. Tell your
doctor:

 * about all of the medicines you take, including over-the-counter medicines,
   vitamins, and herbal supplements.
 * about any other prescription medicines you take, especially ones called TZDs.
 * about all of your medical conditions, including if you have heart failure or
   other heart, liver, or kidney problems. If you have heart failure, it may get
   worse while you take TZDs with BASAGLAR.
 * if you are pregnant, breastfeeding, or plan to become pregnant. It is not
   known if BASAGLAR may harm your unborn or breastfeeding baby.

HOW TO TAKE

The BASAGLAR prefilled pen is a disposable insulin delivery device for use by a
single patient to inject BASAGLAR. Read the Instructions for Use that come with
your BASAGLAR prefilled pen. These instructions provide details on how to
prepare and inject a dose of BASAGLAR, and how to throw away used BASAGLAR
prefilled pens and needles.

Be sure to check your blood sugar levels and use BASAGLAR exactly as your doctor
tells you to. Your doctor may tell you to change your dose because of illness,
increased stress, or changes in your weight, diet, or level of physical activity
or exercise. He or she may also tell you to change your dose because of other
medicines you take.

Before injecting your BASAGLAR
You can inject BASAGLAR yourself, or you can have a trained caregiver inject it
for you. Make sure you or your caregiver:

 * Check your insulin label each time you give your injection. This will help
   you make sure that you are using the correct insulin.
 * Use a new needle for each injection. You can get a serious infection or the
   wrong dose of insulin if you re-use needles.

When you are ready to inject


 * Take BASAGLAR once a day, at the same time each day.
 * Change (rotate) where you inject your insulin with each dose. This can help
   reduce your chance of getting pits, lumps, or thickened skin where you inject
   your insulin. Do not inject your insulin into the exact same spot or where
   the skin has pits or lumps. Avoid injecting into thickened, tender, bruised,
   scaly, hard, scarred, or damaged skin.

Staying safe while taking your BASAGLAR

To stay safe while taking BASAGLAR, be sure you only use BASAGLAR that is clear
and colorless and does not have any particles.

Be sure you do not:

 * mix BASAGLAR with any other type of insulin or solution.
 * drive or use heavy machinery until you know how BASAGLAR affects you.
 * drink alcohol or use other medicines that contain alcohol when taking
   BASAGLAR.

LEARN MORE

BASAGLAR is a prescription medicine. For more information, call 1-800-545-5979.

This summary provides basic information about BASAGLAR but does not include all
information known about this medicine. Read the information that comes with your
prescription each time your prescription is filled. This information does not
take the place of talking with your doctor. Be sure to talk to your doctor or
other health care provider about BASAGLAR and how to take it. Your doctor is the
best person to help you decide if BASAGLAR is right for you.

BV CON BS 14SEP2022

BASAGLAR® is a registered trademark owned or licensed by Eli Lilly and Company,
its subsidiaries, or affiliates.

Indication or Indications. Select to Expand. INDICATION Indication or
Indications. Select to Expand.


INDICATION

BASAGLAR® (bāz-a-glar) is a long-acting insulin used to control high blood sugar
in:

 * adults with type 1 or type 2 diabetes
 * children with type 1 diabetes

It is not known if BASAGLAR is safe and effective in children with type 2
diabetes or in children younger than 6 years with type 1 diabetes. There were no
studies done with BASAGLAR in these groups of children. If your doctor decides
to give your child BASAGLAR, he or she may give you special instructions.

BASAGLAR is not used to treat diabetic ketoacidosis.

 * 

 * Terms of Use
 * Privacy Statement
 * Consumer Health Privacy Notice
 * Accessibility Statement
 * Sitemap

To speak to customer support:
Call (800) 545-5979

This site is intended for US residents aged 18 or older.

PP-BV-US-1858 02/2024 ©Lilly USA, LLC 2024. All rights reserved .

BASAGLAR® and KwikPen® are registered trademarks owned or licensed by Eli Lilly
and Company, its subsidiaries, or affiliates and is available by prescription
only. Lantus® and Toujeo® are registered trademarks of sanofi-aventis U.S. LLC.
BD is a trademark of Becton, Dickinson and Company. beginsulin® is a trademark
of Eli Lilly and Company. Names of Lilly Covered Insulins listed on the Insulin
Value Savings Cards are registered trademarks or trademarks owned or licensed by
Eli Lilly and Company, its subsidiaries or affiliates, and are available by
prescription only. TRICARE® is a registered trademark of the Department of
Defense (DoD), DHA. LillyDirect™ is a trademark owned or licensed by Eli Lilly
and Company, its subsidiaries, or affiliates.


Your Privacy Choices



Cookie Settings

Terms of Use Privacy Statement Consumer Health Privacy Notice Accessibility
Statement Sitemap